A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth ...

The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID ...

A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth ...

Announcing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, ...

SARS-CoV-2 infection was associated with more rapid coronary plaque progression and significantly increased risk for adverse ...

The virus was linked with the rapid growth of plaque in the coronary arteries which increases the chances of major ...

The source of the SARS-CoV-2 virus, which causes COVID-19, remains elusive. With "low confidence, "some federal agencies ...

COVID-19 isn't just a respiratory illness — it can silently attack the heart. New research reveals that the virus accelerates ...

The following is a summary of “Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain),” published in the January 2025 issue of Infectious Disease by Montagud et al ...

This facility will enable critical research on viral pathogens like influenza and SARS-CoV-2, bolstering India's pandemic ...

Some US agencies like the FBI and the Department of Energy support the lab-leak theory, while most elements of the ...